SCHEMBL7072074

SCHEMBL7072074

Clc1cccc(CC2CC3CCC(C2)N3Cc2nc3ccccc3[nH]2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN1 Q05586 3/20 0.53
GRIN2B Q13224 3/20 0.53
DRD4 P21917 3/20 0.50
OPRM1 P35372 1/20 0.46
OPRD1 P41143 1/20 0.46
OPRK1 P41145 1/20 0.46
KCNH2 Q12809 1/20 0.46
CXCR6 O00574 1/20 0.45
ALDH1A1 P00352 3/20 0.43
MAPT P10636 3/20 0.43
TDP1 Q9NUW8 2/20 0.43
KDM4E B2RXH2 2/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
IDO1 P14902 2/20 0.42
HCRTR2 O43614 1/20 0.42
HTT P42858 2/20 0.41
GLA P06280 1/20 0.41
GAA P10253 1/20 0.41
ATM Q13315 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7074975 0.88 GRIN1 (0.56) GRIN1GRIN2BDRD4CXCR6TDP1
SCHEMBL7072578 0.88 GRIN2B (0.67) GRIN1GRIN2BDRD4CXCR6IDO1
SCHEMBL7076802 0.88 GRIN2B (0.56) GRIN1GRIN2BDRD4OPRM1OPRD1
SCHEMBL7079118 0.88 GRIN1 (0.50) GRIN1GRIN2BDRD4OPRM1OPRD1
SCHEMBL7073348 0.88 GRIN1 (0.53) GRIN1GRIN2BDRD4OPRM1OPRD1
SCHEMBL7074921 0.82 GRIN2B (0.56) GRIN1GRIN2BDRD4CXCR6ALDH1A1
SCHEMBL7075826 0.82 GRIN1 (0.56) GRIN1GRIN2BDRD4CXCR6ALDH1A1
SCHEMBL7072398 0.79 GRIN1 (0.53) GRIN1GRIN2BDRD4KCNH2CXCR6
SCHEMBL7071858 0.78 MEN1 (0.49) GRIN1GRIN2BDRD4CXCR6ALDH1A1
SCHEMBL7077264 0.78 GRIN1 (0.54) GRIN1GRIN2BDRD4CXCR6ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1244450-A4 8-AZA-BICYCLO[3.2.1]OCTANE NMDA/NR2B ANTAGONISTS MERCK & CO INC (US) 2003-03-19 EP claimed
EP-1244450-A1 8-AZA-BICYCLO[3.2.1]OCTANE NMDA/NR2B ANTAGONISTS Merck & Co., Inc. (US) 2002-10-02 EP claimed
US-6432976-B1 ANALGESICS; SIDE EFFECT REDUCTION MERCK & CO., INC. 2002-08-13 US claimed
WO-2001032179-A1 8-AZA-BICYCLO[3.2.1]OCTANE NMDA/NR2B ANTAGONISTS MERCK & CO., INC. (US) 2001-05-10 WO claimed
EP-1244450-A4 8-AZA-BICYCLO[3.2.1]OCTANE NMDA/NR2B ANTAGONISTS MERCK & CO INC (US) 2003-03-19 EP disclosed
EP-1244450-A1 8-AZA-BICYCLO[3.2.1]OCTANE NMDA/NR2B ANTAGONISTS Merck & Co., Inc. (US) 2002-10-02 EP disclosed
US-6432976-B1 ANALGESICS; SIDE EFFECT REDUCTION MERCK & CO., INC. 2002-08-13 US disclosed
WO-2001032179-A1 8-AZA-BICYCLO[3.2.1]OCTANE NMDA/NR2B ANTAGONISTS MERCK & CO., INC. (US) 2001-05-10 WO disclosed